{"id":6700,"name":"dRx Capital","slug":"drx-capital","website":"https://www.drxcapital.com","hqGeo":null,"stageFocus":[],"sectorTags":[],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Pear Therapeutics","companyUrl":null,"stage":"Growth / pre‑public (PIPE in connection with SPAC transaction)","sector":"Digital therapeutics / Digital health","investmentYear":null,"description":"Developer of prescription digital therapeutics that combine software and pharmaceuticals to treat conditions such as substance use disorder and insomnia.","amountUsd":null,"relevanceNote":null,"fundName":"Novartis digital health venture fund dRx Capital"},{"companyName":"Omada Health","companyUrl":null,"stage":"Late‑stage growth","sector":"Digital health / chronic disease management","investmentYear":null,"description":"Provider of digital, behavior‑change programs for chronic disease prevention and management delivered via an online platform and remote coaching.","amountUsd":null,"relevanceNote":null,"fundName":"Qualcomm–Novartis joint venture fund dRx Capital"},{"companyName":"Science 37","companyUrl":null,"stage":"Series A (early stage) and PIPE (growth / pre‑public)","sector":"Clinical research / Decentralized trials / Healthtech","investmentYear":null,"description":"Technology‑enabled clinical research platform offering decentralized clinical trial services.","amountUsd":null,"relevanceNote":null,"fundName":"dRx Capital (joint venture between Qualcomm and Novartis; also referenced as dRx Capital (Novartis Pharma AG))"},{"companyName":"H1","companyUrl":null,"stage":"Series B (growth stage)","sector":"Health data / SaaS for life sciences","investmentYear":null,"description":"Healthcare data platform that maps and connects healthcare professionals, organizations, and clinical activity for biopharma and healthcare clients.","amountUsd":null,"relevanceNote":null,"fundName":"Novartis–Qualcomm digital health venture fund dRx Capital"},{"companyName":"Tact.ai","companyUrl":null,"stage":"Late growth stage (equity financing, classified externally as Series D)","sector":"Life‑sciences commercial technology / AI‑enabled CRM for pharma","investmentYear":null,"description":"AI‑based customer engagement platform for life sciences, providing CRM‑like tools to improve how pharma field teams interact with healthcare professionals.","amountUsd":null,"relevanceNote":null,"fundName":"Novartis (dRx Capital) – Novartis’s data and digital health venture fund dRx Capital"},{"companyName":"Vineti","companyUrl":null,"stage":"Series C (growth stage)","sector":"Cell & gene therapy infrastructure / Healthtech SaaS","investmentYear":null,"description":"Software platform to manage and scale personalized and cell/gene therapies, providing orchestration, logistics, and compliance tools.","amountUsd":null,"relevanceNote":null,"fundName":"dRx Capital & CDO Venture Capital (a Novartis investment vehicle)"}],"partnerCount":2,"partners":[{"id":22536,"name":"Eric Boutin","title":"Managing Partner","seniority":null,"focusTags":["digital health","healthcare technology platforms","life sciences","pharma commercialization"],"linkedinUrl":"https://www.linkedin.com/in/eric-boutin/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":22535,"name":"Rana Lonnen","title":"Managing Partner","seniority":null,"focusTags":["digital health","data and digital technology","healthcare AI & ML","pharma R&D optimization"],"linkedinUrl":"https://www.linkedin.com/in/rana-lonnen-769b77109/","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[],"featuredIn":[],"fundraisingResources":[{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":null}